Federal Antimonopoly Service (FAS of Russia) has issued Letter No. АЦ/49132/18 dated 29 June 2018 in which expressed its opinion regarding selling prices for drugs, included in the List of vital and essential drugs (the “Essential drug list”). FAS indicated that these prices, when set by wholesale and retail organizations, shall be dependent on the terms of their purchase.

On 24 April 2018 the Intellectual Property Court published its Decision in case A41 85807/2016 between Swiss-based Novartis AG and local generic Nativa LLC.

At present, the direction of medicine, such as telemedicine, becomes more and more known and the number of questions about the procedure of providing medical assistance using telemedicine is also growing.

The Ministry of Healthcare of the Russian Federation (the “Minzdrav”) has developed draft law aimed to improve regulation of drugs circulation, namely in respect of the determination of drugs interchangeability (the "Draft Law“).

On April 13, 2018 the draft law (hereinafter — the “Draft law”) imposing measures (countermeasures) in response to the hostile acts of the USA and (or) other foreign countries has been introduced to State Duma by both State Duma’s chairman and parliamentary leaders.

On January 19, 2018 State Duma has passed in the first reading the introduced by Russian Government draft law (hereinafter — the “Draft law”) providing changes to the Federal law dated 12.04.2010 No. 61-FZ “On drugs (medicines) circulation” (hereinafter — “61-FZ”).